We are live on
!
Find out more
VHAM
Van Hulzen Asset Management Portfolio holdings
AUM
$1.35B
1-Year Est. Return
22.73%
This Fund
S&P 500
This Quarter
Est. Return
-12.11%
1 Year Est. Return
+22.73%
3 Year Est. Return
+75.53%
5 Year Est. Return
+93.64%
10 Year Est. Return
+300.03%
AUM
$837M
AUM Growth
-$106M
(-11%)
Cap. Flow
+$25.6M
Cap. Flow
% of AUM
3.06%
Top 10 Holdings %
Top 10 Hldgs %
29.85%
Holding
333
New
25
Increased
125
Reduced
93
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$22.2M |
| 2 |
Qualcomm
QCOM
|
+$18.2M |
| 3 |
IBM
IBM
|
+$15.9M |
| 4 |
McDonald's
MCD
|
+$14.4M |
| 5 |
Eaton
ETN
|
+$13.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$19.2M |
| 2 |
Intercontinental Exchange
ICE
|
+$18.2M |
| 3 |
Altria Group
MO
|
+$16.4M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$15.2M |
| 5 |
Darden Restaurants
DRI
|
+$11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.99% |
| 2 | Healthcare | 12.44% |
| 3 | Consumer Staples | 8.15% |
| 4 | Communication Services | 7.14% |
| 5 | Industrials | 6.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Goldman Sachs
GS
$303B
| $451K | 0.05% |
1,519
+377
| +33% | +$117K |
|
177
iShares Core S&P US Growth ETF
IUSG
$33.7B
| $450K | 0.05% |
5,373
+721
| +15% | +$66.1K |
|
178
Ford
F
$55.7B
| $447K | 0.05% |
40,172
+2,830
| +8% | +$38.8K |
|
179
Starbucks
SBUX
$120B
| $444K | 0.05% |
5,816
-28,741
| -83% | -$2.21M |
|
180
Newmont
NEM
$119B
| $442K | 0.05% |
7,414
+64
| +0.9% | +$4.53K |
|
181
Cummins
CMI
$88.7B
| $432K | 0.05% |
2,233
+237
| +12% | +$47.4K |
|
182
Invesco DB US Dollar Index Bullish Fund
UUP
$422M
| $419K | 0.05% |
15,000
-10,400
| -41% | -$285K |
|
183
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.38B
| $418K | 0.05% |
4,421
+331
| +8% | +$32.8K |
|
184
Essex Property Trust
ESS
$18.5B
| $416K | 0.05% |
1,590
| – | – |
|
185
ProShares Short S&P500
SH
$897M
| $416K | 0.05% |
6,300
+1,939
| +44% | +$120K |
|
186
Northwest Bancshares
NWBI
$2.28B
| $408K | 0.05% |
31,900
-1,300
| -4% | -$16.6K |
|
187
ITT
ITT
$19.1B
| $397K | 0.05% |
5,900
| – | – |
|
188
Digital Realty Trust
DLR
$71.7B
| $391K | 0.05% |
3,011
-143
| -5% | -$19.8K |
|
189
Mercury Systems
MRCY
$6.52B
| $388K | 0.05% |
6,027
+168
| +3% | +$10K |
|
|
FITB
190
Fifth Third Bancorp
FITB
$51.8B
| $383K | 0.05% |
11,400
| – | – |
|
191
Franco-Nevada
FNV
$46B
| $381K | 0.05% |
2,895
| – | – |
|
192
Progress Software
PRGS
$1.76B
| $380K | 0.05% |
8,383
+114
| +1% | +$5.42K |
|
|
ETB
193
Eaton Vance Tax-Managed Buy-Write Income Fund
ETB
$458M
| $375K | 0.04% |
24,940
-6,060
| -20% | -$93.4K |
|
194
Abbott
ABT
$187B
| $374K | 0.04% |
3,445
-179
| -5% | -$20.3K |
|
195
Sysco
SYY
$40.3B
| $372K | 0.04% |
4,397
+817
| +23% | +$68.4K |
|
196
Huntington Bancshares
HBAN
$35.5B
| $366K | 0.04% |
30,393
+1,587
| +6% | +$21.1K |
|
|
ITCI
197
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $365K | 0.04% |
6,400
-200
| -3% | -$11.3K |
|
198
iShares Select Dividend ETF
DVY
$23.6B
| $360K | 0.04% |
3,062
-100
| -3% | -$12.5K |
|
199
iShares ESG Advanced MSCI USA ETF
USXF
$1.49B
| $359K | 0.04% |
12,005
+81
| +0.7% | +$2.61K |
|
200
Invesco FTSE RAFI US 1000 ETF
PRF
$10B
| $358K | 0.04% |
12,085
-125
| -1% | -$4.01K |
|
Similar funds
HAM
ME
BFMH
4WM
MC
SEP
AWA
RCM
Van Hulzen Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, Van Hulzen Asset Management held 333 positions worth $837M, down 11% from $943M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Van Hulzen Asset Management deployed $25.6M of net new capital in Q2 2022, opening 25 new positions and adding to 125 existing holdings. Its largest new stake was Walgreens Boots Alliance: 221,780 shares worth $8.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $19.2M trimmed.
- Van Hulzen Asset Management's largest Q2 2022 buy was Walgreens Boots Alliance: 221,780 shares worth $8.4M.
- Van Hulzen Asset Management added most to Johnson & Johnson in Q2 2022, an estimated $22.2M increase.
- Van Hulzen Asset Management's biggest Q2 2022 reduction was Vertex Pharmaceuticals, cutting an estimated $19.2M.
- Van Hulzen Asset Management fully exited State Street Technology Select Sector SPDR ETF in Q2 2022, selling an estimated $15.2M.
- Van Hulzen Asset Management's ten largest holdings make up 30% of its $837M portfolio in Q2 2022.
- Van Hulzen Asset Management opened 25 new positions and closed 37 in Q2 2022.
- Van Hulzen Asset Management's portfolio value fell 11% quarter-over-quarter to $837M.
Based on Van Hulzen Asset Management's 13F filing for Q2 2022, filed 4 Aug 2022.